US Patent Issued to SANOFI BIOTECHNOLOGY, REGENERON PHARMACEUTICALS on Oct. 14 for "Method of diagnosis and treatment of rheumatoid arthritis" (American, French Inventors)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,440,561, issued on Oct. 14, was assigned to SANOFI BIOTECHNOLOGY (Gentilly, France) and REGENERON PHARMACEUTICALS INC. (Tarrytown, N.Y.).

"Method of diagnosis and treatment of rheumatoid arthritis" was invented by Anita Boyapati (Chappaqua, N.Y.), Jerome Msihid (Antony, France) and Moshe E. Zilberstein (North Caldwell, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to the use of an anti-IL6 receptor antibody for treating rheumatoid arthritis in subjects with serum concentrations of certain biomarkers."

The patent was filed on April 24, 2020, under Application No. 16/858,301.

*For further information, including image...